RCM
BLUE

RA Capital Management’s bluebird bio BLUE Stock Holding History

RA Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,921
Closed -$14.3M – 39
2015
Q3 		$14.3M Buy
12,921
+4,477
+53% +$8.16M 2.06% 18
2015
Q2 		$18.4M Sell
8,444
-7,025
-45% -$14.3M 1.85% 18
2015
Q1 		$24.2M Sell
15,469
-23,604
-60% -$31.1M 2.4% 13
2014
Q4 		$46.4M Sell
39,073
-17,191
-31% -$11.5M 4.99% 7
2014
Q3 		$26.1M Buy
56,264
+17,428
+45% +$8.04M 3.09% 10
2014
Q2 		$19.4M Buy
38,836
+2,751
+8% +$882K 1.96% 16
2014
Q1 		$10.6M Hold
36,085
– – 0.76% 24
2013
Q4 		$9.81M Hold
36,085
– – 1.14% 23
2013
Q3 		$12.6M Buy
+36,085
New +$13.4M 1.32% 20

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RA Capital Management's BLUE Position: Q4 2015 in Review

RA Capital Management sold out of bluebird bio (BLUE) in Q4 2015, closing a stake of 12,921 shares — an estimated $14.3M sold.

RA Capital Management first reported a position in BLUE in Q3 2013 and held it in 9 quarters. The position peaked at $46.4M in Q4 2014. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

  • RA Capital Management reported no remaining bluebird bio position as of Q4 2015 after selling out during the quarter.
  • RA Capital Management sold 12,921 bluebird bio shares in Q4 2015, an estimated $14.3M.
  • RA Capital Management first reported a position in bluebird bio in Q3 2013 and held it in 9 quarters.
  • RA Capital Management's bluebird bio position peaked at $46.4M in Q4 2014.
  • 193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on RA Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.